American Heart Association Release:Three Therapies May Reverse Action of New Blood-Thinning Drug

6/21/2012 9:50:48 AM

DALLAS, June 20, 2012 (GLOBE NEWSWIRE) -- Three approaches may reverse the blood thinning action of the new oral anticoagulant drug apixaban when a person suffers an accident or needs emergency surgery, according to laboratory research presented in the American Heart Association's Emerging Science Series webinar.

Read at GlobeNewswire

Read Article at

Related Companies

News Categories

• GlobeNewswire

• American Heart Association

• Clinical - Research